Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CGNT +8.4%, CASY +4.1%, NSTG +3.6% (guidance), ANIP +3% (guidance)
Other news:
- LYRA +25.5% (Topline Results from BEACON Phase 2 Study of LYR-220)
- ADEA +7.5% (resolves litigation)
- HUT +7% (August production update)
- WRK +6.9% (WestRock and Smurfit Kappa (SMFKY) announce transaction to create a global leader in sustainable packaging)
- GERN +6.8% (CFO to retire names new CFO)
- FLAG +4.8% (to complete business combination with CLDI)
- BLCO +4.5% (announced the U.S. commercial launch of MIEBO (perfluorohexyloctane ophthalmic solution) for the treatment of the signs and symptoms of dry eye disease) GCT +3.9% (enters into definitive "stalking horse" agreement to purchase the assets of Noble House Home Furnishings for $85 million in connection with Noble House's Chapter 11 bankruptcy proceedings)
- FNGR +3.6% ($300 mln mixed shelf)
- CBAY +3.2% (prices $225 mln offering common stock and pre-funded warrants)
- ANIP +3% (receives FDA approval and launch of Estradiol Tablets USP)
- TRNS +2% (amended Share Purchase Agreement with John Cummins and Ross Lane associated with the purchase of all of the outstanding capital stock of Cal OpEx Limited)
- HUMA +1.9% (Top Line Results from Phase 2/3 Trial of Human Acellular Vessel (HAV) in Treatment of Patients with Vascular Traumaw)
- APLD +1.7% (entered into facility extension agreement with Oncor Electricity Delivery for the transmission and metering of power to hosting facility in Garden City TX)
- CHRS +1.4% (increased the amount of shares that could be issued and sold pursuant to its ATM with TD Cowen in an amount equal to $28.75 million)
- NVX +1% (announces results of engineering study on proprietary all-dry zero-waste cathode synthesis process)
Analyst comments:
- CTRE +1.9% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)